Featured at NVIDIA GTC Taiwan 2026: NYB.AI Stands Alongside the World’s Leading AI Innovators

On 1 June 2026, NYB.AI, the AI drug discovery spinoff of NYB Group, was featured in a video accompanying Jensen Huang's keynote address at NVIDIA GTC Taiwan 2026—one of NVIDIA's premier global events focused on artificial intelligence, accelerated computing, and next-generation innovation.

This video was presented as part of NVIDIA CEO Jensen Huang's keynote address, placing NYB.AI among a select group of companies highlighted to a global audience of technology leaders, researchers, investors, and industry decision-makers.

Selected from NVIDIA Inception's global ecosystem of more than 25,000 startups, NYB.AI was featured in the video's opening sequence, underscoring its role at the intersection of artificial intelligence and life sciences, as one of the world's leading innovators recognized by NVIDIA for advancing the next generation of AI-powered solutions across industries.

The recognition reflects the growing importance of agentic AI and scientific computing in transforming drug discovery.

Built on more than seven years of research collaboration with Nanyang Technological University (NTU) and further advanced through engagement within the NVIDIA ecosystem, NYB.AI's Vecura 2.0 platform enables autonomous scientific workflows that integrate AI models, biological data, and molecular tools into coordinated discovery systems.

By combining frontier AI capabilities with deep biological expertise and NVIDIA-accelerated computing, NYB.AI is helping shape a new era of scientific discovery—one where intelligent systems act as coordinated research agents to accelerate the path from research insights to potential therapeutic breakthroughs.